Skip to content
Save up to 80% on your medications — Fast delivery
Amantadine
Guaranteed quality
Discreet shipping
Returns

Amantadine

5 customer reviews
Delivery: 4–7 days
Secure payment methods
24/7 Support
Active ingredient: Amantadine
Package Per unit Price
SSL Secure
Certified pharmacy
Money-back guarantee

Amantadine is an antiviral medicine used as an antiparkinsonian drug. It is for adults with Parkinson’s disease or certain drug-induced movement problems. Its main benefit is improving movement by increasing dopamine release and blocking NMDA receptors.

What is it?

Amantadine is an antiviral medication and an antiparkinsonian drug used mainly for movement symptoms such as rigidity, tremor, and slowed movement in Parkinson’s disease. It is used in adults who need symptom relief tied to dopamine pathways in the brain. The key benefit is its dual action: it increases dopamine release and blocks NMDA receptors, which can improve motor control.

Composition

Amantadine contains the active ingredient amantadine hydrochloride.

Like other oral pills, it also contains inactive ingredients (excipients) that help form the tablet and control stability. Excipients can matter for people with rare intolerances, yet most patients focus on the active ingredient because it drives clinical effect.

How to use?

For Parkinson’s disease, a common starting plan in clinical practice is 100 mg once daily, then increasing to 100 mg twice daily after several days if tolerated and if symptom control is still incomplete. Dose selection is strongly influenced by kidney function because amantadine is cleared through the kidneys; reduced renal clearance can raise blood levels and side-effect risk even at standard doses.

A few timing and routine points make a measurable difference:

  • Take it at the same time daily to reduce peak–trough swings that can trigger dizziness or jitteriness.
  • If you take two doses daily, many patients do best with morning and early afternoon timing to protect sleep.
  • Do not double a dose after a missed one; that is a common trigger for confusion, insomnia, and palpitations.

One sentence that saves trouble: dose changes should be gradual.

How does it work?

  • Oral tablets: Take 100 mg by mouth 1 time per day in the morning, preferably after breakfast for the first 7 days.
  • If needed and prescribed, increase to 100 mg by mouth 2 times per day; the second dose is taken in the early afternoon, not late in the day.
  • Duration: use for the full course prescribed by the clinician; do not stop suddenly unless instructed.
  • Route: oral only.

Indications

Amantadine is used to ease Parkinson’s disease symptoms like muscle rigidity, tremor, and bradykinesia (slowness of movement). It is also used for drug-induced extrapyramidal symptoms, which are movement problems that can happen with some antipsychotic medicines.

Comparison

Treatment choice depends on the symptom you want to change: tremor, rigidity, bradykinesia, dyskinesia, or drug-induced extrapyramidal symptoms. Amantadine sits in a distinct spot because it is not just dopaminergic; NMDA antagonism can be clinically meaningful when dyskinesia is the limiting factor in a levodopa plan.

Option (active ingredient) How it differs from Amantadine Typical place in therapy
Levodopa/carbidopa Direct dopamine replacement strategy Core therapy for many Parkinson’s patients
Dopamine agonists (e.g., pramipexole, ropinirole) Stimulate dopamine receptors directly; impulse-control risks can be prominent Used in selected patients, often younger
Anticholinergics (e.g., benztropine) Reduce tremor in some cases but raise confusion/constipation risk More limited use due to tolerability

Contraindications

  • Hypersensitivity to amantadine or a prior allergic reaction to amantadine
  • Severe renal failure
  • Decompensated heart failure
  • Clinically significant arrhythmia history
  • Closed-angle glaucoma
  • Pregnancy and breastfeeding
  • History of seizures
  • Unstable psychiatric illness

Not recommended for

This medication is not for you if you have a past allergy to amantadine. It also needs specialist caution if you have kidney problems, certain heart rhythm issues, glaucoma, seizures, or unstable mental health. Pregnancy and breastfeeding are situations where routine use is usually avoided.

Side effects

Side effects vary with dose, age, and kidney function. Many are dose-related and show up early, then improve after adjustment.

Common side effects reported with Amantadine include:

  • Nausea, reduced appetite
  • Dizziness, headache
  • Dry mouth
  • Insomnia or daytime sleepiness
  • Blurred vision or light sensitivity

Some side effects need faster medical review, as they can signal intolerance or a serious reaction:

  • New confusion, hallucinations, severe agitation, or abrupt mood change
  • Palpitations, fainting, chest discomfort, or signs of abnormal heart rhythm
  • Severe rash, facial swelling, wheeze, or other hypersensitivity signs (unusual or allergic reaction to amantadine)

You may feel dizzy at first.
Driving can be affected.
Alcohol can worsen sedation.

Practical tip: if dizziness shows up in the first days, stand up in two steps (sit on the bed edge, then stand). Patients who rush this are the ones who fall.

Common mistakes

Taking the second dose too late in the day is the #1 reason patients told me they stopped Amantadine after a few nights of poor sleep. Morning and early afternoon timing prevents many insomnia complaints.

Another frequent mistake is stacking medicines with similar side effects. Combining Amantadine with multiple anticholinergic drugs (for example, bladder antispasmodics plus benztropine) can turn mild dry mouth into constipation, blurred vision, and confusion.

People also misread “more energy” as a sign to increase caffeine or add stimulants. Central nervous system stimulants can amplify jitteriness, raise heart-rate, and worsen anxiety.

Last one is simple: skipping hydration when dry mouth starts. Dry mouth is not just annoying; it raises dental risk and makes swallowing tablets feel harder than it should be.

Doctor opinions

Neurologists often reach for Amantadine when a patient’s main problem is stiffness, slowness, or troublesome dyskinesia on levodopa-based therapy, because NMDA blockade can reduce overactive signalling linked with involuntary movements. Clinicians also watch for a “trade-off” pattern: motor symptoms improve, but sleep and thinking speed can worsen in the first one to two weeks, then settle once the dose is stable.

Doctors in the UAE frequently tie their monitoring plan to MOHAP-aligned safety habits: check kidney function, review the full medication list for anticholinergic load, and ask directly about vivid dreams, impulse changes, and new anxiety. Those questions sound personal, yet they catch the side effects that patients often delay reporting until they become disruptive.

Amantadine is not a first pick for everyone with Parkinson’s. Older adults with baseline confusion, people with untreated narrow-angle glaucoma, and patients with significant arrhythmia history often need a different approach.

Practical tip: bring a short “before vs after” symptom note to follow-ups (walking speed, freezing episodes, tremor severity, sleep). Two lines in your phone notes is enough, and it helps dose decisions.

Frequently asked questions

Amantadine is not classified as an antidepressant; it is an antiviral medication and an antiparkinsonian drug with dopaminergic and NMDA-antagonist effects. Some people feel more drive or alertness after starting it, which can be mistaken for an antidepressant effect. Clinical classification and safety monitoring rely on regulator-reviewed drug information used internationally, including EMA-style SmPC frameworks and MOHAP-aligned prescribing practice in the UAE. The main therapeutic targets remain movement symptoms and certain medication-induced movement disorders.

Memory complaints can occur, most often as part of broader CNS side effects such as confusion, poor concentration, or hallucinations. “Amnesia” is not the usual pattern; it is more often short-term forgetfulness during dose initiation, dose escalation, or when kidney function is reduced and levels rise. WHO medicine-safety principles for CNS-active drugs emphasise assessing new cognitive symptoms early, because they can progress quickly in older adults. In 2026 clinical practice, dose reduction or timing changes often resolves mild cognitive fog.

Amantadine belongs to the adamantanes, a class defined by the adamantane chemical structure used to build several antiviral and CNS-active molecules. Clinically, it is also described as an NMDA receptor antagonist and a dopamine modulator. This dual classification is why it can affect both movement symptoms and side effects like insomnia or vivid dreams. EMA and other regulators list it under antiparkinsonian agents, while also recognising its historical antiviral indication.

Many patients feel some change within the first week, often in stiffness or “getting going” speed, while full benefit can take a few weeks once the dose is stable. In 2026, FDA labeling and EMA product information still describe gradual titration and monitoring during early treatment. Early side effects such as dizziness or sleep disruption often appear before the motor benefits settle in. MOHAP-aligned monitoring in the UAE typically focuses on blood pressure standing/sitting, sleep quality, and mental status during the first 1–3 weeks. If nothing changes by week four, prescribers often reassess the target symptom and the overall regimen.

Amantadine was used historically for influenza A, yet widespread resistance reduced its usefulness for routine flu prevention and treatment. In 2026, WHO guidance still emphasizes vaccination and other antivirals rather than amantadine for routine influenza care. Public-health approaches backed by WHO focus more on vaccination and antivirals with better activity against circulating strains, which is why amantadine is rarely chosen for influenza management in 2026. Some patients still encounter the indication in older medical references, so the continued presence of that history can be confusing. In practice, most prescriptions today are written for neurological indications.

Avoid adding stimulants or extra caffeine to “push through” early tiredness, because it can amplify jitteriness and insomnia. Alcohol can intensify dizziness or sedation in people who already feel unsteady. Medicines that increase anticholinergic effects can also worsen dry mouth, constipation, and blurred vision, which is why prescribers review the full list, including bladder medicines and antihistamines. EMA-style prescribing information also supports extra caution in people with renal impairment, where avoidance is really about preventing accumulation.

Front view Front view
Side view Side view
Back view Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.

Amantadine — Comparison with alternatives

Reviews and Experiences

H
Hassan, 62
Abu Dhabi
6 weeks
Verified
My neurologist added Amantadine for stiffness and the shuffling walk. The first week I felt dizzy when standing, but by week three my steps were smoother and I needed less ‘warm-up’ in the morning.
14/02/2025
M
Mariam, 38
Dubai
3 weeks
Verified
I used it for medication-induced stiffness from an antipsychotic. The tight jaw and restlessness eased after about 10 days. Sleep got lighter, so I moved the dose earlier and it improved.
21/09/2025
O
Omar, 70
Sharjah
10 days
Verified
It helped my tremor a bit, but I stopped because I felt confused at night and had vivid dreams. My doctor later said my kidneys were not as strong as before, and the dose may have been too much for me.
08/01/2025
S
Saleh, 55
Al Ain
2 months
Verified
I noticed fewer involuntary movements on my levodopa plan by week four. Dry mouth was constant, so I kept water nearby and used sugar-free gum, which made it manageable.
30/11/2025
L
Leila, 47
Dubai
2 weeks
Verified
I expected a quick fix for my stiffness, but the insomnia was hard to ignore and the benefit was only mild. My doctor adjusted the timing, but I still rated it as average for me.
17/06/2025

Sources

  1. MedlinePlus, U.S. National Library of Medicine (2024). Amantadine — Drug information
  2. PubMed, U.S. National Library of Medicine (2020). Amantadine — MeSH Descriptor Data (adamantanes; pharmacology indexing record)
  3. FDA (2018). SYMMETREL (amantadine hydrochloride) — Prescribing Information (label)
  4. World Health Organization (WHO) (2025). Therapeutics and COVID-19: living guideline
  5. European Medicines Agency (EMA) (2023). Summary of Product Characteristics (SmPC) — amantadine-containing medicinal products (regulatory product information)
Get our free app Shop faster and track your orders 3.8 · 1,437 reviews Install